Abstract
After many years of experiments and clinical experience, liver transplantation is now considered an optimal therapy for various types of end stage liver disease [1]. The first liver transplantation was performed by Welch in 1955 in a dog and the first human liver transplantation was performed by Starzl et al. in 1963 [2, 3]. Early clinical results were disappointing. The advent of modern immunosuppressive agents has improved survival rates in both children and adults. The survival rates at 1, 3, 5, and 10 years in children are 82%, 80%, 78%, and 76%, respectively [4]. The indications for liver transplantation for varieties of end stage liver diseases are shown in Table 12.1.1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Welch CS., National Institute of Health consensus development conference statement, Liver transplantation. June 20–23,1983, Hepatology 1983;3: Suppl 107S–110S
Welch CS., A note on transplantation of whole liver in dogs. Transplant Bull 1955, 2: 54
Starzl TE, Marchioro TL, Von Kaulla KN, Hermann G, Brittain RS, Waddell UR., Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117: 659–676
Goss JA, Shackleton CR, McDiarmid SV, Maggard M, Swenson K, Seu P, Vargas J, Martin M, Ament M, Brill J, Harrison R, Busuttil RW., Long-term results of pediatric liver transplantation. An analysis of 569 transplants. Ann Surg 1998; 228: 411–420
Starzl TE, Demetris AJ, Van Thiel D., Liver transplantation (1). N Engl J Med 1989; 321: 1014–1022
Kawasaki S, Makuuchi M, Matsunami H, Hashihura Y, Ikegami T, Nakazawa Y, Chisuwa H, Terada M, Miyagawa S., Living related liver transplantation in adults. Ann Surg 1998; 227: 269–274
Terpstra OT, Schalm SW, Weimar W, Willemse PJ, Baumartner D, Groenland TH, ten Kate FW, Porte RJ, de Rave S, Reuvers CB et al. Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med 1988; 319: 1507–1511
Sudan DL, Shaw BW Jr, Fox IJ, Langnas AN., Long-term followup of auxiliary orthotopic liver transplantation for the treatment of fulminant hepatic failure. Surgery 1997; 122: 771–778
Shah AN, Dodson F, Fung J., Role of nuclear medicine in liver transplantation. Semin Nucl Med 1995; 25: 36–48
Stieber AC, Gordon RD, Galloway JR., Orthotopic liver transplantation. In: Zakim D, Boyer TD. (eds). Hepatology. A text book of liver disease. WB Saunders, Philadelphia, 1996, pp 1759–1780
Brown RK, Memsic LD, Busuttil RW, Pusey E, Ray RA, Kangarloo H, Hawkins RA., Accurate demonstration of hepatic infarction in liver transplant recipients. J Nucl Med 1986; 27: 1428–1431
Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, Wiesner RH, Krom RA., Ischemic-type biliary complication after orthotopic liver transplantation. Hepatology 1992; 16: 49–53
Von Moll LK, Juni JE, Merion RM., Scintigraphic demonstration of accessory hepatic duct leak following liver transplantation. J Nucl Med 1988; 29: 259–262
Lantsberg S, Lanchbury EE, Drolc ZA., Evaluation of bile duct complications after orthotopic liver transplantation by hepatobiliary scanning. Nucl Med Commun 1990; 11: 761–769
Madacsy L, Velosy B, Lonovics J, Csernay L., Differentiation between organic stenosis and functional dyskinesia of the sphincter of Oddi with amyl nitrite-augmented quantitative hepatobiliary scintigraphy. Eur J Nucl Med 1994; 21: 203–208
Bhatnagar A., Nifedipine interventional cholescintigraphy. A new method for assessing sphincter of Oddi? Indian J Nucl Med 1997; 12: 93–96
Krishnamurthy S, Krishnamurthy GT., Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin. J Nucl Med 1997; 38: 1824–1830
Hawkins RA, Hall T, Gambhir SS, Busuttil RW, Huang SC, Glickman S, Marciano D, Brown RK, Phelps ME., Radionuclide evaluation of liver transplant. Semin Nucl Med 1988; 18: 199–212
Jain A, Khanna A, Molmenti EP, Rishi N, Fung JJ., Immunosuppressive therapy Surgical Clinic of North America 1999; 79: 59–76
Shakil AO, Mazariegos GV, Kramer DJ., Fulminant hepatic failure. Surgical Clinic of North America 1999; 79; 77–108
Boudjema K, Cherqui D, Jaeck D, Chenard-Neu MP, Steib A, Freis G, Becmeur F, Brunot B, Simeoni U, Bellocq JP, et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 1995; 59: 218–223
Metselaar HJ, Hesselink EJ, de Rave S, ten Kate FJ, Lameris JS, Groenland TH, Reuvers CB, Weimar W, Terpstra OT, Schalm SW., Recovery of failing liver after auxiliary heterotopic transplantation. Lancet 1990; 335: 1156–1157
Krishnamurthy S, Krishnamurthy GT., Technetium-99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology 1989; 9: 139–153
Buyck D, Bonnin F, Bernuau J, Belghiti J, Bok B., Auxiliary liver transplantation in patients with fulminant hepatic failure: hepatobiliary scintigraphy followup. Eur J Nucl Med 1997; 24: 138–142
Bismuth H, Houssin D., Reduced-size orthotopic liver graft in hepatic transplantation in children. Surgery 1984; 95: 367–372
Raia S, Nery JR, Mies S., Liver transplantation from live donors. Lancet 1989; 2: 497
Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Eng J Med 1990; 322: 1505–1507
Emond JC., Clinical application of living-related liver transplantation. Gastroenterol Clin North Am 1993; 22: 301–315
Donovan J., Nonsurgical management of biliary tract disease after liver transplantation. Gastroenterol Clin North Am 1993; 22: 317–336
Reding R, Goyet JV, Delbeke I, Sokal E, Jamart J, Janssen M, Otte J., Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr 1999; 134: 280–286
Grewal HP, Thistlethwaite JR Jr., Loss GE, Fisher JS, Cronin DC, Siegel CT, Newell KA, Bruce DS, Woodle ES, Brady L, Kelly S, Boone P, Oswald K, Millis JM., Complications in 100 living-liver donors. Ann Surg 1998; 228: 214–219
Stratta RJ, Wood RP, Langnas AN, Hollins RR, Bruder KJ, Donovan JP, Burnett DA, Lieberman RP, Lund GB, PillenTJ et al. Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery 1989; 106: 675–684
Mazariegos GV, Molmenti EP, Kramer DJ., Early complications after orthotopic liver transplantation. Surgical Clinic of North America 1999; 79: 109–129
Krishnamurthy S, Krishnamurthy GT., Nuclear hepatology: where is it heading now? J Nucl Med 1988; 29: 1144–1149
Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM., Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 1998; 207: 21–32
Sasaki N, Shiomi S, Iwata Y, Nishiguchi S, Kuroki T, Kawabw J, Ochi H., Clinical usefulness of scintigraphy with Tc-99m galactosyl-human serum albumin for prognosis of cirrhosis of the liver. J Nucl Med 1999; 40: 1652–1656
Hwang E, Taki J, Shuke N, Nakajima K, Kinuya S, Konoshi S, Michigishi T, Aburano T, Tonami N., Preoperative assessment of residual hepatic functional reserve using Tc-99m-DTPA-galactosylhuman serum albumin dynamic SPECT. J Nucl Med 1999; 40: 1644–1651
Uetake M, Koizumi K, Yagawa A, Nogata H, Tezuka T, Kono H, Ozawa T, Kusano T, Miyabukuro M, Hosaka M., Use of Tc-99m DTPA galactosyl human serum albumin to predict postoperative residual liver function. Clin Nucl Med 1999; 24: 428–434
Krishnamurthy S, Krishnamurthy GT., Functional imaging in nuclear hepatology. Indian J Nucl Med 1997; 12: 216–232
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Krishnamurthy, G.T., Krishnamurthy, S. (2000). Liver Transplantation. In: Nuclear Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22654-4_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-22654-4_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22656-8
Online ISBN: 978-3-662-22654-4
eBook Packages: Springer Book Archive